ENDPOINTS

Kennedy's FDA cuts raise questions about 'trigger' for ...

Last week's thousands of FDA job cuts will take a major chunk out of what the ag...

Novo Nordisk, HHS clash in court over IRA drug selection

Novo Nordisk focused on a unique argument in federal appeals court on Tuesday in...

Rallybio ends development in rare disorder; ImmunityBio...

Plus, news about KalVista, Kaken Pharmaceutical, Lyell and Tango Therapeutics: ...

Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ ...

Johan Luthman has been running R&D at Lundbeck since 2019, and part of the neuro...

Cartesian reveals long-term mid-stage data for cell the...

Cartesian Therapeutics said its autologous CAR-T therapy has shown “sustained be...

Exclusive: Merida Biosciences gets $121M to treat autoi...

A scrappy team of drug developers has come together to create new medicines for ...

US commission calls for $15B biotech investment to blun...

A congressional commission is calling for at least a $15 billion federal investm...

Commission calls for $15B biotech investment amid Trump...

A congressional commission is calling for at least a $15 billion federal investm...

Trump administration hikes Medicare Advantage payments ...

The Trump administration will hike payments to Medicare Advantage insurers by mo...

HHS says it may revisit policy for anti-obesity drugs

The government said it “may consider future policy options” for anti-obesity med...

Federal judge in Minnesota dismisses drugmakers' 340B l...

A federal judge in Minnesota knocked down challenges from two drugmakers against...

PureTech rejects cash exit proposal from Nordic Capital...

PureTech Health, a Boston biopharma company that has created drug developers lik...

Rare disease hub at CDER and CBER faces new reality wit...

Amy Comstock Rick joined the FDA last November, and she not only survived the wi...

RFK Jr. won’t testify before key Senate committee this ...

HHS Secretary Robert F. Kennedy Jr. won’t be appearing before a Senate panel on ...

‘This is self-inflicted’: Leerink’s David Risinger on t...

As the markets continued to fall Monday in response to the Trump administration’...

Drug tool and packaging makers to feel brunt of Trump t...

Pharma tool and packaging production companies are readying themselves for direc...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.